Monday, July 15, 2024

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

More Than 200 Million Doses of COVID Shots Dumped Due to Diminishing Demand

thrown away vaccines

Nearly two years after the introduction of COVID-19 biologics around the world, the pharmaceutical industry is facing a waning demand for these products. Scott Rosenstein, a New York-based health care adviser to Eurasia Group said: Supply is exceeding demand in much of the world, even with many countries rolling out booster shots. Once the perception set […]

Moderna CEO Was Paid $18.2 Million in 2021

Stephane Bancel

As COVID-19 vaccine sales continue to soar, Moderna Chief Executive Stephane Bancel’s total personal financial compensation increased by 41 percent in 2021, reaching $18.2 million. The company’s total revenue rose 2,200 percent in 2021, jumping from $803 million to $18.5 billion.1 2 Moderna partnered with the National Institute of Allergy and Infectious Diseases (NIAID), headed […]

Pfizer CEO Received $24.3 Million in Total Compensation for 2021

Albert Bourla

Pfizer CEO Albert Bourla, who recently announced that a fourth COVID-19 vaccine dose will be necessary for everyone who has already gotten three doses, was awarded $24.3 million in personal financial compensation in 2021. In addition to his $1.69 million salary, which increased by 15 percent, Bourla took home a cash incentive of $8 million, […]

U.S. Consumers Warned About Fraudulent Coronavirus Testing Sites

coronavirus testing tent

The U.S. Department of Health and Human Services Office of Inspector General has issued a warning to the public about fraudulent schemes and scams related to COVID-19 services and testing that involve telemarketing calls, text messages, social media platforms, and door-to-door visits.1 At the outset of the SARS-CoV-2 pandemic, there was a proliferation of fraudulent […]

Pfizer Withdraws EUA Application for COVID Shot in India After Regulator Asks for Independent Safety Study

Pfizer's BNT162b2 biologic

Pfizer, Inc. has withdrawn its emergency use authorization (EUA) application for its experimental BNT162b2 (also known as “Comirnaty”) messenger RNA (mRNA) COVID-19 biologic (developed in collaboration with Germany’s BioNTech) in India.1 Pfizer was the first pharmaceutical company to apply for an EUA to distribute a COVID biologic in India in 2021. However, India’s regulatory agency […]

Search in Site

To search in site, type your keyword and hit enter

Search